Object of the Bill
The object of the Bill is to provide a regulatory framework that Facilitates the safe development and application of Biotechnology; to designate a national focal point, and a competent authority; to establish a national biosafety committee and Institutional biosafety committees ; to provide mechanism to regulate research, development and general release of genetically modified organism and for related matters
Bill Document
Other Attachments
| 1 |
THE NATIONAL BIOSAFETY ACT 2017 11-01-2018 Laid Document.pdf
|
||||||
|---|---|---|---|---|---|---|---|
|
|||||||
| 2 |
SCT3-17-Report on the National Biotechnology and Biosafety Bill, 2012(Including Minority Report).pdf
|
||||||
|
|||||||
| 3 |
SCT3-13-Report on the National Biotechnology and Biosafety Bill, 2012.pdf
|
||||||
|
|||||||
The National Bio Technology And Bio Safety Bill, 2012
Sponsored By Hon. Maria Kiwanuka (Minister of Finance, Planning and Economic Development)
Committee: The Committee on Finance, Planning and Economic Development
Start
First Reading/Committee
First read in the 9th Parliament and laid on Table in the 10th Parliament on the 15/11/2016
Second Reading
Bill read for the Second time in the floor of Parliament.
Third Reading
First passed on the 04/10/2017 and after reconsideration was passed on 28/11/2018
Presentation/Waiting Assent
First Represented on the 11/12/2017 and Under Re-Consideration, was presented on 28/11/2018
Assented by President
The President declined to assent the Bill for an Act.
End
Bill passed on 21/12/2017
The President declined to assent the Bill for an Act.
Bill Withdrawn on 11/06/2013
Waiting for Assent. Bill is waiting for the President to assent to it. When the Floor of Parliament has passed a Bill, it shall be presented to the President, and the President shall declare either that he assents to the Bill or that he withholds assent.